DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,113,952 | -6.0% | 4,490 | -3.4% | 0.56% | +0.4% |
| Q2 2023 | $1,185,493 | +0.5% | 4,648 | -0.7% | 0.55% | -7.2% |
| Q1 2023 | $1,179,275 | -6.1% | 4,679 | -1.2% | 0.60% | -8.2% |
| Q4 2022 | $1,256,425 | +2.7% | 4,734 | -0.0% | 0.65% | -4.8% |
| Q3 2022 | $1,223,000 | -4.4% | 4,736 | -6.2% | 0.68% | -0.4% |
| Q2 2022 | $1,279,000 | -11.7% | 5,047 | +2.2% | 0.69% | 0.0% |
| Q1 2022 | $1,449,000 | +4.2% | 4,940 | +16.9% | 0.69% | +3.5% |
| Q4 2021 | $1,390,000 | +5.5% | 4,225 | +0.0% | 0.66% | +5.9% |
| Q3 2021 | $1,317,000 | +18.9% | 4,224 | +2.3% | 0.63% | +12.0% |
| Q2 2021 | $1,108,000 | +19.3% | 4,130 | 0.0% | 0.56% | +12.9% |
| Q1 2021 | $929,000 | +11.9% | 4,130 | +18.3% | 0.50% | -0.8% |
| Q4 2020 | $830,000 | +11.0% | 3,490 | +0.4% | 0.50% | +1.6% |
| Q3 2020 | $748,000 | +5.8% | 3,475 | +0.1% | 0.49% | +4.9% |
| Q2 2020 | $707,000 | +40.8% | 3,470 | -4.3% | 0.47% | +14.1% |
| Q1 2020 | $502,000 | -6.3% | 3,626 | +8.9% | 0.41% | +16.5% |
| Q4 2019 | $536,000 | +40.3% | 3,331 | +25.9% | 0.35% | +31.3% |
| Q3 2019 | $382,000 | +1.1% | 2,645 | 0.0% | 0.27% | +1.5% |
| Q2 2019 | $378,000 | +8.3% | 2,645 | +0.4% | 0.26% | +10.0% |
| Q1 2019 | $349,000 | +32.2% | 2,635 | +3.1% | 0.24% | +17.6% |
| Q4 2018 | $264,000 | -4.7% | 2,557 | +0.5% | 0.20% | +9.1% |
| Q3 2018 | $277,000 | +4.9% | 2,545 | -5.0% | 0.19% | +0.5% |
| Q2 2018 | $264,000 | +1.1% | 2,679 | +3.1% | 0.19% | 0.0% |
| Q1 2018 | $261,000 | +7.0% | 2,599 | -1.0% | 0.19% | +5.1% |
| Q4 2017 | $244,000 | +8.4% | 2,624 | 0.0% | 0.18% | 0.0% |
| Q3 2017 | $225,000 | +1.4% | 2,624 | 0.0% | 0.18% | -1.1% |
| Q2 2017 | $222,000 | -17.5% | 2,624 | -16.6% | 0.18% | -4.8% |
| Q1 2017 | $269,000 | +4.7% | 3,146 | -4.8% | 0.19% | +5.0% |
| Q4 2016 | $257,000 | -1.2% | 3,306 | 0.0% | 0.18% | -4.3% |
| Q3 2016 | $260,000 | -31.8% | 3,306 | -12.3% | 0.19% | -31.0% |
| Q2 2016 | $381,000 | -6.2% | 3,771 | -11.9% | 0.27% | -10.0% |
| Q1 2016 | $406,000 | +9.4% | 4,281 | 0.0% | 0.30% | +2.4% |
| Q4 2015 | $371,000 | +14.2% | 4,281 | +12.1% | 0.29% | +12.2% |
| Q3 2015 | $325,000 | -0.6% | 3,819 | 0.0% | 0.26% | +7.4% |
| Q2 2015 | $327,000 | -5.5% | 3,819 | -6.4% | 0.24% | -5.8% |
| Q1 2015 | $346,000 | +0.9% | 4,079 | +2.0% | 0.26% | +0.8% |
| Q4 2014 | $343,000 | +13.6% | 3,999 | +0.5% | 0.26% | +12.2% |
| Q3 2014 | $302,000 | +1.0% | 3,979 | +4.9% | 0.23% | 0.0% |
| Q2 2014 | $299,000 | +3.8% | 3,793 | -1.4% | 0.23% | -0.4% |
| Q1 2014 | $288,000 | -11.4% | 3,845 | -8.6% | 0.23% | -12.5% |
| Q4 2013 | $325,000 | +11.3% | 4,205 | 0.0% | 0.26% | +2.3% |
| Q3 2013 | $292,000 | +21.2% | 4,205 | +10.2% | 0.26% | +17.4% |
| Q2 2013 | $241,000 | – | 3,815 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |